Cargando…
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action
Targeted therapies have come into prominence in the ongoing battle against non-small cell lung cancer (NSCLC) because of the shortcomings of traditional chemotherapy. In this context, indole-based small molecules, which were synthesized efficiently, were subjected to an in vitro colorimetric assay t...
Autores principales: | Altıntop, Mehlika Dilek, Akalın Çiftçi, Gülşen, Yılmaz Savaş, Nalan, Ertorun, İpek, Can, Betül, Sever, Belgin, Temel, Halide Edip, Alataş, Özkan, Özdemir, Ahmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916685/ https://www.ncbi.nlm.nih.gov/pubmed/36768971 http://dx.doi.org/10.3390/ijms24032648 |
Ejemplares similares
-
Synthesis and Evaluation of New Benzodioxole- Based Thiosemicarbazone Derivatives as Potential Antitumor Agents
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2016) -
Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2018) -
Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9
por: Özdemir, Ahmet, et al.
Publicado: (2017) -
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors
por: Sever, Belgin, et al.
Publicado: (2020) -
Design, Synthesis,
and Evaluation of a New Series
of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
por: Erdönmez, Burak, et al.
Publicado: (2023)